enVVeno Medical Corporation
NASDAQ:NVNO
Overview | Financials
| Company Name | enVVeno Medical Corporation |
| Symbol | NVNO |
| Currency | USD |
| Price | 0.759 |
| Market Cap | 14,602,775 |
| Dividend Yield | 0% |
| 52-week-range | 0.74 - 5.7 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Mr. Robert A. Berman |
| Website | https://www.envveno.com |
An error occurred while fetching data.
About enVVeno Medical Corporation
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD



